Hungarian Pharma Leaders Mini-Survey 2010
View this page in:
Main findings of the survey:
- Companies are optimistic about their 2010 revenues with 75% of respondents expecting their revenues to increase this year compared to 2009.
- Three quarters of the companies who participated in our survey plan to continue with their cost cutting measures in 2010.
- 100% of the respondents identified the drug support system, namely, the lack of its transparency as one of the problem areas.
- Approximately four fifths of the respondents identified foreign exchange risk and tax treatment of certain transactions, e.g., promotions and samples, as problem areas.
We trust that you will find both our conclusions and summary useful and that our insights will prove valuable to a wide audience, including companies, regulators and the general public.
Click here to download the survey (PDF, 303kb)